Hypersensitive teeth. Part II: Treatment.
If the hydrodynamic theory for pain transmission were accepted, occlusion of the patent dentinal tubules would appear to be essential for treatment efficacy. There are many compounds with seemingly varied chemical forms that have been shown to be effective. Their exact mode of action however, is not clearly defined because well-designed, nonbiased, and controlled comparison studies between agents are lacking. The various toothpastes may have ingredients that actually occlude patent tubules or they may cause secondary desensitization by irrational or abrasive action. In any pain study, the nature of the placebo effect and other psychogenic factors play a significant role. Fluoride preparation with and without iontophoresis has been shown to alter tubule structure and form microprecipitates. The natural desensitization process, although slow, is nature's protection, allowing dentinal sclerosis of secondary dentin formation. Although the resin-adhesive systems, especially the new light-cured dentin bonding agents, appear immediately to be effective, the effect on the pulp remains unknown. Perhaps a combination of iontophoresis with sodium fluoride and light-cured dentin bonding material may yield protection and desensitization at a high level of predictability. With the population trends toward a more geriatric society, further research, knowledge, and understanding of dentinal hypersensitivity is of paramount importance. The expected increase in longevity of the dentition suggests that dentin exposure and sensitivity will increase as a clinical problem. There is a clear time-age relationship involved in gingival recession, erosion and attrition of the teeth, and the need for periodontal surgical therapy. For total comprehensive care, patient comfort is important and should be provided along with sound periodontal health and ideal restorative function.
D000269:Adhesives / Q000627:therapeutic use; D002126:Calcium Hydroxide / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D019343:Citric Acid; D003188:Composite Resins / Q000627:therapeutic use; D003807:Dentin Sensitivity / Q000188:drug therapy*; D005459:Fluorides / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D009566:Nitrates / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D011060:Poloxalene / Q000627:therapeutic use; D017680:Potassium Compounds; D012835:Silver Nitrate / Q000627:therapeutic use; D013324:Strontium / Q000627:therapeutic use; D014002:Tin Fluorides / Q000627:therapeutic use
D000269:Adhesives; D002951:Citrates; D003188:Composite Resins; D005938:Glucocorticoids; D009566:Nitrates; D010710:Phosphates; D017680:Potassium Compounds; D014002:Tin Fluorides; C012980:fluorophosphate; D019343:Citric Acid; D011060:Poloxalene; D012835:Silver Nitrate; D002126:Calcium Hydroxide; D005459:Fluorides; C023844:potassium nitrate; D013324:Strontium